Devices descending from K093942
119 later devices reach Ensite Velocity System V1.3 through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +11 | K223094 | EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software Upgrade… | Abbott Medical | 2022 | 10 | — |
| +11 | K222209 | AcQMap High Resolution Imaging and Mapping System | Acutus Medical, Inc. | 2022 | 2 | — |
| +12 | K252164 | NorthStar™ Mapping System | Imricor Medical Systems | 2026 | 1 | — |
| +12 | K252302 | CARTO™ 3 EP Navigation System V8.1 | Biosense Webster, Inc. | 2025 | 2 | — |
| +12 | K231415 | EnSite™ X EP System | Abbott Medical | 2023 | 9 | — |
| +12 | K231091 | AcQMap High Resolution Imaging and Mapping System | Acutus Medical, Inc. | 2023 | 0 | — |
| +12 | K230606 | AcQMap® High Resolution Imaging and Mapping System | Acutus Medical, Inc. | 2023 | 0 | — |
| +13 | K261119 | NorthStar Mapping System (MAP01 or MAP01-01) | Imricor Medical Systems, Inc. | 2026 | 0 | — |
| +13 | K252972 | CARTO™ 3 EP Navigation System V8.4 | Biosense Webster, Inc. | 2026 | 0 | — |
| +13 | K254085 | CARTO™ 3 EP Navigation System V9.0 with PIU Plus | Biosense Webster, Inc. | 2026 | 0 | — |
| +13 | K242016 | EnSite™ X EP System | Abbott Medical | 2024 | 8 | — |
| +14 | K252429 | Vektor Computational ECG Mapping System (vMap®) | Vektor Medical, Inc. | 2025 | 0 | — |
| +14 | K252013 | EnSite™ X EP System | Abbott Medical | 2025 | 3 | — |
| +14 | K251463 | EnSite™ X EP System, AutoMark Index Software License (ENSITE-AMI-01); EnSite™ X EP… | Abbott Medical | 2025 | 0 | — |
| +14 | K251234 | EnSite™ X EP System | Abbott Medical | 2025 | 4 | — |
| +15 | K260885 | VERAFEYE Imaging and Guidance System (VF-VIS-002) | Luma Vision Limited | 2026 | 0 | — |
| +15 | K260212 | EnSite™ X EP System | Abbott Medical | 2026 | 2 | — |
| +16 | K261729 | EnSite™ X EP System | Abbott Medical | 2026 | 0 | — |
| +16 | K262006 | EnSite™ X EP System | Abbott Medical | 2026 | 0 | — |